Virtu Financial
STAB

Virtu Financial’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Virtu Financial’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-102,385
Closed -$13K – 2467
2022
Q3 		$13K Buy
+102,385
New +$21.6K ﹤0.01% 1490
2022
Q2 		– Sell
-157,678
Closed -$50K – 2320
2022
Q1 		$50K Buy
157,678
+126,715
+409% +$135K ﹤0.01% 1139
2021
Q4 		$71K Buy
30,963
+17,778
+135% +$52.5K 0.01% 1244
2021
Q3 		$30K Buy
+13,185
New +$50K ﹤0.01% 1349

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Virtu Financial's STAB Position: Q4 2022 in Review

Virtu Financial sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2022, closing a stake of 102,385 shares — an estimated $13K sold.

Virtu Financial first reported a position in STAB in Q3 2021 and held it in 4 quarters. The position peaked at $71K in Q4 2021. 29 funds tracked by Wall St. Rank hold STAB as of Q4 2022.

  • Virtu Financial reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 102,385 Statera Biopharma, Inc. Common Stock shares in Q4 2022, an estimated $13K.
  • Virtu Financial first reported a position in Statera Biopharma, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Virtu Financial's Statera Biopharma, Inc. Common Stock position peaked at $71K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.